Cardiology 1 Flashcards
Mayo Clinic Internal Medicine
What Systemic Diseases Commonly cause heart disease too?
Hyper/hypothyroidism AIDS
Diabetes Mellitus Marfan Syndrome
Amyloidosis Friedreich Ataxia
Hemochromatosis Osteogenesis Imperfecta
Carcinoid Lyme Disease
Hypereosinophilic Syndrome
Scleroderma
SLE
RA
Cardiac Effects of Hyperthyroidism
tachycardia, increased cardiac output, decreased PVR with a widened pulse pressure. Atrial Fib, Angina, palpitations, presyncope, DOE
Common Presentation of Hyperthyroidism
older woman, weight loss, weakness, tachycardia with or without angina or a fib. Tremor of fingers/tongue +/- goiter
Description of the PE findings of Hyperthyroid associated heart disease.
tachycardia, bounding pulse with a wide pulse pressure.
Forceful apical impulse and a systolic ejection murmur. A fib in 10-20%. (always check thyroid function in a fib.
Cardiac Effects of Hypothyroidism
cardiac enlargement, decreased function, bradycardia, decreased myocardial contractility and stroke volume and increased PVR. 30% with pericardial effusion. Possibly increased cholesterol
Common presentation of hypothyroidism
elderly patient with depression, lethargy and slowed mentaion. Hair loss, macroglossia, sinus bradycardia, EKG with low voltage QRS with prolonged QRS, PR and/or QT. Increased cardiac size
Description of the PE findings of Hypothyroid associated heart disease
Cardiac enlargement due to myocardial disease or to pericardial effusion. Decreased pulse volume, sometimes heart failure. Accelerated atherosclerosis.
Cardiac Effects of Diabetes Mellitus
Premature atherosclerosis, increased hypertension and hyperlipidemia, angina and myocardial infaction may be atypical or silent. Congestive heart failure common first sign of CAD. Other cardiomyopathy without atherosclerosis from microvascular disease may exist.
Treatment of cardiovascular disease associated with Diabetes Mellitus
BARI trial showed CABG better than STENT if multivessel disease. (no clopidogrel in that trial)
Risk factors include glycemic control and urinary protein excretion. AGRESSIVE BP lowering reduces mortality, glycemic control does not reduce incidence of cardiac problems in the short term.. Statins and fibrates, aspirin, ACE inhibitors
Cardiac Effects of Amyloidosis
Extracellular deposition of insoluble proteins in organs. Caused by monoclonal immunoglubulin free light chains.
Genetics of Amyloidosis
familial type is autosomal dominant and due to mutant transthyretin
“wild-type” or “senile type” is due to noraml transthyretin deposisiton
Secondary type is related to amyloid A protein, often from multiple myeloma
Cardiac findings of primary Amyloidosis
Usually AL type.(90% with heart manifestations) enlarged heart with thickened myocardium, conduction abnormalities, valvular clogging by depositied proteins. arrhythmias, heart failure with left ventricular diastolic dysfuntion and sudden cardiac death.
Organs involved in Amyloidosis
heart, liver, kidney, GI tract and nervous tissue.
Causes of Secondary Amyloidosis
RA, TB, chronic infection, neoplasia (multiple myeloma) and chronic renal failure. Cardiac involvement may occure, but not common.
Clinical Presentaion of Amyloidosis
CHF, arrhythmia, sudden death, angina, pericardial effusion, murmurs.
Patient 40-70 years old presents with dyspnea and progressive edema. May also have hoarsness, carpal tunnerl or peripheral neuropathy. LOW-V
OLTAGE QRS with or without other conduction abnormalities coupled with echocardiographic findings of thick wall and preserved ventricular function.
Diagnostic indicators of Amyloidosis
EKG, Echo (increase in LV wall thickness in spite of EKG with low or normal voltage. Atria may be dilated, valves thickened with mild regurg. pericardial effusion. Abnormal Diastolic function (restrictive filling)
Treatment of Amyloidosis
Correcting the underlying problem does not usually help the cardiac problems. Try experimental protocols.
Cardiac effects of Hemochromatosis
congestive heart failure